Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2005
10/19/2005EP1465909A4 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof
10/19/2005EP1423373B1 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
10/19/2005EP1354054B1 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/19/2005EP1353948B1 Soluble cyclic analogues of the beta amyloide peptide
10/19/2005EP1339438B1 Preventing transplant rejection in the eye
10/19/2005EP1292618B1 Vip-related peptides for the treatment of sexual disorders in women
10/19/2005EP1259251B1 Novel method for down-regulation of amyloid
10/19/2005EP1131056B1 Particles based on polyamino-acid(s) and methods for preparing same
10/19/2005EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent
10/19/2005EP1104482B1 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
10/19/2005EP1100541B1 Hydrogel for the therapeutic treatment of aneurysms
10/19/2005EP1036057B1 Radio-opaque polymer biomaterials
10/19/2005EP1033998B1 Suppressing beta-amyloid-related changes in alzheimer's disease
10/19/2005EP1017415B1 Product for promoting dural or meningeal tissue growth comprising collagen
10/19/2005EP1015583B1 Protein containing an srcr domain
10/19/2005EP0948255B1 Improved chondrogenic differentiation of human mesenchymal stem cells
10/19/2005EP0918539B1 Vaccine for b-cell malignancies
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
10/19/2005EP0831891B1 Oxidant scavengers
10/19/2005EP0814774B1 Reduction of adhesions using controlled delivery of active oxygen inhibitors
10/19/2005EP0771208B1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685064A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/19/2005CN1685058A Peptides with anti-hypertensive properties
10/19/2005CN1685055A Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
10/19/2005CN1685039A Secreted acid phosphatase (SAPM) is present only in pathogenic mycobacteria and expressed selectively at phagosomal PH
10/19/2005CN1684978A Glycosylated human granulocyte colony-stimulating factor (G-CSF) isoform
10/19/2005CN1684977A Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
10/19/2005CN1684975A Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/19/2005CN1684973A Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
10/19/2005CN1684972A Conjugates comprised of polymer and HIV gp41-derived peptides and their use in therapy
10/19/2005CN1684738A Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
10/19/2005CN1684737A Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
10/19/2005CN1684706A Methods and compositions for activating or inhibiting VEGF-D and VEGF-C
10/19/2005CN1684705A Methods of use of compounds with preptin function
10/19/2005CN1684704A Interferon and immunologublin FC fragment hybrid
10/19/2005CN1684703A Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
10/19/2005CN1684702A Method of treating tumors
10/19/2005CN1684701A Ophthalmologic irrigation solutions and method
10/19/2005CN1684700A Gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/19/2005CN1684694A Inhibition of protein kinase C alpha for treatment of diabetes mellitus and cardiovascular diseases
10/19/2005CN1684693A Boronic acid polyvalent salts for treating thrombosis
10/19/2005CN1684683A Potent inhibitor of HCV serine protease
10/19/2005CN1684588A Use of proteases for decomposing allergens
10/19/2005CN1683551A Method for preparing cow fetus agent by composite enzyme method and its composite health product
10/19/2005CN1683408A Glucagon-like peptide analog, its composition and its using method
10/19/2005CN1683399A Wasp antibiotic peptide and its preparing method and use
10/19/2005CN1683395A Nuclear factor-K B P65 subunit antagonistic peptide and its use
10/19/2005CN1683392A Chinese hard tick neuropeptide and its preparing method and use
10/19/2005CN1683008A Collagen polypeptide preparation for supplementing calcium and its preparing method
10/19/2005CN1683007A Compound medicine for improving intestine tissue healing under celiac infectious condition
10/19/2005CN1683006A Heterosides peptide injection liquor for improving animal immunological function
10/19/2005CN1683005A Recombinant human granulocyte colony stimulating factor precursor liposome and its preparing method
10/19/2005CN1683004A Methods for treating pain
10/19/2005CN1682903A Method for purifying and preparing anti-tumor factor-cathepsin beta inhibiting factor from soybean or bean dregs
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/19/2005CN1223677C Gene associated with esophagus cancer
10/19/2005CN1223608C Caspase-8 interacting proteins
10/19/2005CN1223607C Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application
10/19/2005CN1223605C Polypeptide medicine for inhibiting SARS corona virus, and derivatives and use thereof
10/19/2005CN1223603C Bioactive peptide No.26
10/19/2005CN1223602C Bioactive peptide No.11
10/19/2005CN1223378C Cyclodextrin containing glycopeptides antibiotic pharmaceutical compositions
10/18/2005US6956146 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
10/18/2005US6956110 Genes involved in the molecular paths of tumor suppression and/or resistance to viruses
10/18/2005US6956107 Antibody, homologues, or analogues or fragments, peptide, or peptidomimetic used as serene protease inhibitor (factor D inhibitor)
10/18/2005US6956106 Ti-3 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation
10/18/2005US6956105 Chandra: a Th1-specific protein
10/18/2005US6956103 Glaucoma therapeutics and diagnostics
10/18/2005US6956102 Human N-methyl-D-aspartate receptor subunits nucleic acids encoding same and uses therefor
10/18/2005US6956051 amphiphilic drug-oligomer conjugates comprising a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety; therapeutic agents coupled to amphiphilic oligomers
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956027 N-terminally chemically modified protein compositions and methods
10/18/2005US6956026 Use of exendins for the reduction of food intake
10/18/2005US6956025 Crosslinked hemoglobin immobilized on polyoxyethylene glycol
10/18/2005US6956023 Materials and methods for providing nutrition to neonates
10/18/2005US6956022 Increasing blood platelet formation by administering a parathyroid hormone or a derivative
10/18/2005US6956021 Stable spray-dried protein formulations
10/18/2005US6955905 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use
10/18/2005US6955903 Enzymatic polypeptide for use in treating lactose intolerance
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955897 Number of accessory gland proteins from Drosophila. The invention also provides an accessory gland protein which is toxic to insect cells and can be used to kill or inhibit the development of insects. Methods of controlling insects are
10/18/2005US6955895 Nucleic acid encoding the receptor; use drug screening
10/18/2005US6955894 cytokines; for increasing/decreasing signal transduction; metalloproteases; for treating inflammation during treatment of septic shock, arthritis, and/or multiple sclerosis
10/18/2005US6955893 Method for preventing spoilage of food with bacteriophage
10/18/2005US6955891 Reagents for assaying Bacillus anthracis lethal factor protease
10/18/2005US6955888 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
10/18/2005US6955883 Life sciences business systems and methods
10/18/2005US6955822 Lactone bearing absorbable polymers
10/18/2005US6955818 for control of an external parasite on an animal of agricultural worth comprising 0.1 to 40% by weight of at least one spinosyn, and a non-irritant topically acceptable carrier, for example, tripropylene glycol methyl ether and benzyl alcohol
10/18/2005US6955813 Therapy for injured muscles
10/18/2005US6955811 Methods of inhibiting immune response suppression by administering antibodies to OX-2
10/18/2005US6955807 IL-2 selective agonists and antagonists
10/18/2005CA2333160C Additives for crustacean or fish feeds and feeds
10/18/2005CA2299504C Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
10/18/2005CA2006929C Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
10/13/2005WO2005095633A1 A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds
10/13/2005WO2005095613A1 Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF
10/13/2005WO2005095610A1 Nucleic acid expressed in the hypothalamus or muscle tissue and uses thereof in diagnoses
10/13/2005WO2005095609A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide